JPWO2020227457A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020227457A5 JPWO2020227457A5 JP2021565723A JP2021565723A JPWO2020227457A5 JP WO2020227457 A5 JPWO2020227457 A5 JP WO2020227457A5 JP 2021565723 A JP2021565723 A JP 2021565723A JP 2021565723 A JP2021565723 A JP 2021565723A JP WO2020227457 A5 JPWO2020227457 A5 JP WO2020227457A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- bispecific antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962844966P | 2019-05-08 | 2019-05-08 | |
| US201962844970P | 2019-05-08 | 2019-05-08 | |
| US201962844995P | 2019-05-08 | 2019-05-08 | |
| US201962844959P | 2019-05-08 | 2019-05-08 | |
| US201962844976P | 2019-05-08 | 2019-05-08 | |
| US62/844,976 | 2019-05-08 | ||
| US62/844,995 | 2019-05-08 | ||
| US62/844,970 | 2019-05-08 | ||
| US62/844,966 | 2019-05-08 | ||
| US62/844,959 | 2019-05-08 | ||
| PCT/US2020/031749 WO2020227457A1 (en) | 2019-05-08 | 2020-05-07 | Materials and methods for modulating t cell mediated immunity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533538A JP2022533538A (ja) | 2022-07-25 |
| JPWO2020227457A5 true JPWO2020227457A5 (zh) | 2023-05-16 |
Family
ID=73051172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021565723A Pending JP2022533538A (ja) | 2019-05-08 | 2020-05-07 | Ｔ細胞媒介性免疫を調節するための材料及び方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11667712B2 (zh) |
| EP (1) | EP3965818A4 (zh) |
| JP (1) | JP2022533538A (zh) |
| KR (1) | KR20220017892A (zh) |
| CN (1) | CN113966231A (zh) |
| AU (1) | AU2020267504A1 (zh) |
| BR (1) | BR112021022089A2 (zh) |
| CA (1) | CA3139508A1 (zh) |
| CL (1) | CL2021002905A1 (zh) |
| CO (1) | CO2021015998A2 (zh) |
| CR (1) | CR20210548A (zh) |
| DO (1) | DOP2021000229A (zh) |
| EC (1) | ECSP21087921A (zh) |
| IL (1) | IL287817A (zh) |
| JO (1) | JOP20210297A1 (zh) |
| MA (1) | MA55903A (zh) |
| MX (1) | MX2021013532A (zh) |
| PE (1) | PE20220763A1 (zh) |
| SG (1) | SG11202112021QA (zh) |
| TW (1) | TW202108618A (zh) |
| WO (1) | WO2020227457A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210284731A1 (en) * | 2020-03-13 | 2021-09-16 | Janssen Biotech, Inc. | Methods and materials for modulating an immune response |
| WO2022180271A1 (en) | 2021-02-26 | 2022-09-01 | LAVA Therapeutics N.V. | Antibodies that bind CD123 and gamma-delta T cell receptors |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| CA2467738A1 (en) | 2001-12-03 | 2003-06-12 | Abgenix, Inc. | Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| JP2008511337A (ja) | 2004-09-02 | 2008-04-17 | ジェネンテック・インコーポレーテッド | ヘテロ多量体分子 |
| EP1870459B1 (en) | 2005-03-31 | 2016-06-29 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| ES2395969T3 (es) | 2006-03-24 | 2013-02-18 | Merck Patent Gmbh | Dominios de proteínas heterodiméricas genéticamente modificados |
| JP2009541275A (ja) | 2006-06-22 | 2009-11-26 | ノボ・ノルデイスク・エー／エス | 二重特異性抗体の生産 |
| US20090155275A1 (en) | 2007-07-31 | 2009-06-18 | Medimmune, Llc | Multispecific epitope binding proteins and uses thereof |
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
| US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
| US8227577B2 (en) | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
| WO2010045340A1 (en) | 2008-10-14 | 2010-04-22 | Centocor Ortho Biotech Inc. | Methods of humanizing and affinity-maturing antibodies |
| AU2010245011B2 (en) | 2009-04-27 | 2015-09-03 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| IN2012DN02485A (zh) * | 2009-09-03 | 2015-08-28 | Hoffmann La Roche | |
| CN110066339A (zh) | 2010-04-20 | 2019-07-30 | 根马布股份公司 | 含异二聚体抗体fc的蛋白及其制备方法 |
| JP2013537414A (ja) | 2010-08-05 | 2013-10-03 | アナプティスバイオ インコーポレイティッド | Ｉｌ−１７に対する抗体 |
| CN108341868B (zh) | 2010-11-05 | 2022-06-07 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| HUE038225T2 (hu) | 2011-08-23 | 2018-10-29 | Roche Glycart Ag | Bispecifikus, T-sejtaktiváló antigénkötõ, molekulák |
| HRP20211773T1 (hr) | 2011-11-04 | 2022-03-04 | Zymeworks Inc. | Stabilna heterodimerni dizajn antitijela s mutacijama u fc domeni |
| BR112014015018A2 (pt) | 2011-12-19 | 2020-10-27 | Synimmune Gmbh | moléculas de anticorpo biespecífico e seu método de produção, bem como composição farmacêutica e molécula de ácido nucleico |
| US9907820B2 (en) * | 2013-10-25 | 2018-03-06 | Board Of Regents, The University Of Texas System | Polyclonal gamma delta T cells for immunotherapy |
| KR102359264B1 (ko) | 2014-04-10 | 2022-02-04 | 라바 테라퓨틱스 비.브이. | 인간 Vγ9Vδ2 T 세포에 결합하는 면역글로불린 |
| MA44594B1 (fr) | 2015-05-29 | 2020-09-30 | Memorial Sloan Kettering Cancer Center | Anticorps anti-ctla-4 et méthodes d'utilisation de ceux-ci |
| CN110536901B (zh) | 2016-12-26 | 2024-06-18 | 协和麒麟株式会社 | 与髓鞘少突胶质细胞糖蛋白结合的抗体 |
| US11236145B2 (en) * | 2017-03-23 | 2022-02-01 | Immatics Biotechnologies Gmbh | T cell receptors and immune therapy using the same against PRAME positive cancers |
| EP3743081A4 (en) | 2018-01-23 | 2021-12-01 | New York University | SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR |
| MX2022010664A (es) | 2020-02-27 | 2022-11-30 | Janssen Biotech Inc | Materiales y métodos para modular una respuesta inmunitaria. |
| US20210284731A1 (en) | 2020-03-13 | 2021-09-16 | Janssen Biotech, Inc. | Methods and materials for modulating an immune response |
| TW202233674A (zh) | 2020-10-28 | 2022-09-01 | 美商健生生物科技公司 | 用於調節δγ鏈介導之免疫的組成物及方法 |
-
2020
- 2020-05-07 CR CR20210548A patent/CR20210548A/es unknown
- 2020-05-07 AU AU2020267504A patent/AU2020267504A1/en active Pending
- 2020-05-07 PE PE2021001851A patent/PE20220763A1/es unknown
- 2020-05-07 CA CA3139508A patent/CA3139508A1/en active Pending
- 2020-05-07 WO PCT/US2020/031749 patent/WO2020227457A1/en unknown
- 2020-05-07 MX MX2021013532A patent/MX2021013532A/es unknown
- 2020-05-07 KR KR1020217036132A patent/KR20220017892A/ko unknown
- 2020-05-07 TW TW109115171A patent/TW202108618A/zh unknown
- 2020-05-07 JP JP2021565723A patent/JP2022533538A/ja active Pending
- 2020-05-07 MA MA055903A patent/MA55903A/fr unknown
- 2020-05-07 JO JOP/2021/0297A patent/JOP20210297A1/ar unknown
- 2020-05-07 CN CN202080043002.2A patent/CN113966231A/zh active Pending
- 2020-05-07 US US16/869,401 patent/US11667712B2/en active Active
- 2020-05-07 EP EP20801607.1A patent/EP3965818A4/en active Pending
- 2020-05-07 BR BR112021022089A patent/BR112021022089A2/pt unknown
- 2020-05-07 SG SG11202112021QA patent/SG11202112021QA/en unknown
-
2021
- 2021-11-03 IL IL287817A patent/IL287817A/en unknown
- 2021-11-04 CL CL2021002905A patent/CL2021002905A1/es unknown
- 2021-11-04 DO DO2021000229A patent/DOP2021000229A/es unknown
- 2021-11-26 CO CONC2021/0015998A patent/CO2021015998A2/es unknown
- 2021-12-03 EC ECSENADI202187921A patent/ECSP21087921A/es unknown
-
2023
- 2023-04-25 US US18/306,401 patent/US20240150464A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210032357A1 (en) | Cd20 binding molecules and uses thereof | |
| KR102068600B1 (ko) | Pdl-1 항체, 그 약학적 조성물 및 그 용도 | |
| RU2019141289A (ru) | АНТИ-SIRPα АНТИТЕЛА | |
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| RU2018119165A (ru) | Антитело против лиганда 1 запрограммированной гибели клеток (pd-l1), его антигенсвязывающий фрагмент и их медицинское применение | |
| JP2020501531A5 (zh) | ||
| JP2017529838A5 (zh) | ||
| JP2019500892A5 (zh) | ||
| JP2017535257A5 (zh) | ||
| JP7257971B6 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| JP2018534933A5 (zh) | ||
| EP3645741A2 (en) | Anti-4-1bb antibodies and methods of making and using thereof | |
| JP2018510636A5 (zh) | ||
| JP2015509947A5 (zh) | ||
| AU2018348429A1 (en) | Multispecific antibody | |
| JP2020514277A5 (zh) | ||
| RU2017114968A (ru) | Связывающие молекулы, а именно антитела, способные связываться с l1cam (cd171) | |
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JPWO2019224718A5 (zh) | ||
| JP2020513759A5 (zh) | ||
| JP2024024114A5 (zh) | ||
| JP2020522280A5 (zh) | ||
| RU2019104980A (ru) | Анти-icos антитела | |
| JP2020522281A5 (zh) | ||
| JP2017521054A5 (zh) |